More information: Silvia Vaena et al, Aging-dependent mitochondrial dysfunction mediated by ceramide signaling inhibits antitumor T cell response, Cell Reports (2021).

A team of researchers from the Changchun Institute of Applied Chemistry has developed a nanogel-based strategy to enhance the ...

An experimental mRNA vaccine that supercharges existing cancer treatments could be laying the groundwork for a “universal” cancer vaccine, according to the team behind the breakthrough. Scientists at ...

A study led by Prof. Liang Xingjie's team from the National Center for Nanoscience and Technology of the Chinese Academy of ...

A personalized neoantigen vaccine may be effective in patients with clear cell renal cell carcinoma, shared David A. Braun, ...

We designed an anti-CD19 enhanced (armored) CAR T-cell product (huCART19-IL18) that secretes interleukin-18 to enhance antitumor activity.

Dr. Olalekan O. Oluwole explained how CAR T is used to treat high-risk blood cancers and highlighted the potential of ...

Marseille, France Monday, July 21, 2025, 12:00 Hrs [IST] ...

Prof. LIANG Xingjie's team from the National Center for Nanoscience and Technology, along with Prof. GONG Ningqiang from the University of Science and Technology of China, has developed a biomimetic ...

The less robust antitumor effects of CAR T-cell therapies when evaluated in patients with solid tumor malignancies have been attributed to the complex tumor microenvironment, antigen heterogeneity, ...

By Pooja Toshniwal Paharia New research reveals how common dietary proteins like bovine serum albumin (BSA) or ovalbumin (OVA ...

Novel T cell receptor therapy shows early anti-tumor activity Afami-cel Phase I trial shows noteworthy responses in synovial sarcoma Date: January 9, 2023 Source: University of Texas M. D ...